GYNE Benign Disorders of the Upper and Lower Genital Tract, Blueprints Flashcards

1
Q

Most common cause of labial fusion

A

Exogenous androgen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common form of enzymatic deficiency

A

21-hydroxylase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

21-hydroxylase deficiency: Associated condition

A

Congenital adrenal hyperplasia (CAH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Congenital adrenal hyperplasia (CAH): Hormone elevated

A

17α-hydroxyprogesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Congenital adrenal hyperplasia (CAH): Serum cortisol, increased vs decreased

A

Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Congenital adrenal hyperplasia (CAH): Treatment

A

Exogenous cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Congenital adrenal hyperplasia (CAH): Mechanism of exogenous cortisol

A

Negative feedback on pituitary > decrease ACTH > inhibition of adrenal gland stimulation > decrease in androgens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary amenorrhea + cyclic pelvic pain: Condition

A

1) Imperforate hymen
2) Transverse vaginal septum
3) Vaginal atresia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Accumulation of menstrual flow behind the hymen in the vagina

A

Hematocolpos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The caudal portion of the Müllerian ducts develops into

A

Uterus and upper vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Structure that must be canalised for normal vagina to form

A

Mullerian tubercle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Failure of mullein tubercle to canalise results in

A

Transverse vaginal septum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common site of transverse vaginal septum

A

Between upper 1/3 and lower 2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Occurs when the lower vagina is replaced by fibrous tissue and on PE reveals a vaginal dimple

A

Vaginal atresia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vaginal atresia, management

A

Vaginal pull-through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Congenital absence of vagina and absence or hypoplasia of all or part of the cervix, uterus, and fallopian tubes

A

Vaginal agenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Vaginal agenesis is aka

A

Meyer-Rokitansky-Kuster-Hauser syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T/F Ovary is hypoplastic in vaginal agenesis

A

F, normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vaginal agenesis: T/F Normal external genitalia

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vaginal agenesis: T/F Normal secondary sexual characteristics (breast development, axillary, and pubic hair)

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vaginal agenesis: T/F Normal ovarian function

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vaginal agenesis: T/F Phenotypically female

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Vaginal agenesis: T/F Genotypically female

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Vaginal agenesis: Management

A

1) Non-surgical with the use of dilators

2) Surgical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Vaginal agenesis: Most common surgical procedure used

A

McIndoe procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Vaginal agenesis: T/F Will be unable to carry a pregnancy

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Inflammatory dermatosis that is associated with a risk for vulvar skin Ca in postmenopausal women

A

Lichen sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Inflammatory dermatosis associated with vaginal adhesions and erosive vaginitis

A

Lichen planus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

T/F Lichen planis carries a risk of vulvar skin cancer

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Inflammatory dermatosis that generally occurs in women in their 50s and 60s

A

Lichen planus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Skin disorder of the vulva that leads to a scratch–itch cycle

A

Lichen simplex chronicus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Management of nonneoplastic epithelial disorders of vulva

A

1) Lifestyle

2) Topical steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

High-potency topical steroids that can be used to treat lichen sclerosis or lichen planus, and severe lichen simplex chronicus

A

Clobetasol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

T/F There is no role for topical estrogens or testosterone in the treatment of nonneoplastic epithelial disorders of vulva

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Most common tumor found on the ulva

A

Epidermal inclusion cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

T/F Epidermal inclusion cysts usually result from occlusion of a pilosebaceous duct or a blocked hair follicle

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Symmetric white, thinned skin on labia, perineum, and perianal region; shrinkage and agglutination of labia minora

A

Lichen sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Multiple shiny, flat, red-purple papules, usually on the inner aspects of the labia minora and vestibule with lacy white changes; often erosive

A

Lichen planus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Red moist lesions on the vulva, sometimes scaly; usually asymptomatic but sometimes pruritic

A

Vulvar psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Sweat glands found throughout the mons pubis and labia majora

A

Apocrine sweat glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

An infrequently occurring chronic pruritic papular eruption in the vulva that localizes to areas where apocrine glands are found

A

Fox-Fordyce disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Skin disease that most commonly affects areas bearing apocrine sweat glands or sebaceous glands

A

Hidradenitis suppurativa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Paraurethral glands are aka

A

Skene glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Location of Bartholin glands

A

4 o’clock and 8 o’clock positions of vaginal orifice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Bartholin cyst affects which part of the gland

A

Duct, gland itself remains unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Bartholin duct cyst, management: 2cm

A

Can be left untreated or managed with sitz baths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Bartholin duct cyst, management: >40 years old

A

Biopsy to rule out Bartholin gland Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Catheter that can be used to manage complicated or troublesome Bartholin duct cyst

A

Word catheter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Done for recurrent Bartholin’s duct cysts or abscesses

A

Marsupialization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Bartholin duct cyst: Adjunct antibiotic therapy is only recommended when

A

1) Drainage culture is positive for N. gonorrheae

2) Refractory to simple surgical treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Remnants of the mesonephric ducts of the Wolffian system found in the vagina

A

Gartner’s duct cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Gartner’s duct cysts: Found most commonly in

A

Anterior lateral aspects of upper vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Gartner’s duct cysts: T/F Most are asymptomatic

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Gartner’s duct cysts: Management

A

Excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Elevated soft red papules on the vulva tha contain an abnormal proliferation of blood vessels

A

Cherry hemangiomas aka Campbell de Morgan spots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

T/F Isolated congenital anomalies of the cervix are rare

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

25% of women who were exposed in utero to ___have an associated cervical hypoplasia, cervical collars, cervical hoods, cock’s comb cervix, and pseudo polyps

A

DES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

T/F DES exposure in utero are at increased risk of cervical insufficiency in pregnancy

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

T/F Clear cell adenocarcinoma of the cervix and vagina is common in women exposed to DES in utero

A

F, occurs in only 0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Caused by intermittent blockage of an endocervical gland

A

Nabothian cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

T/F Nabothian cyst expand to no more than 1 cm in diameter

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

T/F Nabothian cysts are more commonly found in postmenopausal women

A

F, menstruating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

T/F Nabothian cysts are usually symptomatic

A

F, asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

T/F Nabothian cysts require no treatment

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Remnants of the mesonephric ducts of the Wolffian system found in the cervix

A

Mesonephric cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Nabothian vs mesonephric cysts: Lie deeper in the cervical stroma and on the external surface of the cervix

A

Mesonephric cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Red or purple lesion on the cervix associated with cyclic pelvic pain and dyspareunia

A

Endometriosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

T/F Cervical polyps are often asymptomatic

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Cervical polyps: Most common symptom

A

Intermenstrual or postcoital spotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

T/F Cervical polyps are not usually considered a premalignant condition

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Cervical polyps: Management

A

Removed to decrease the likelihood of masking irregular bleeding from another source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Leiomyomas are aka

A

Myomas or fibroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

T/F Leiomyomas may arise in the cervix

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Leiomyoma of cervix: T/F Can cause intermenstrual bleeding

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

T/F When evaluating an asymptomatic cervical fibroid, the possibility of cervical cancer should be ruled out

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Management for symptomatic fibroid

A

Hysterectomy > myomectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

T/F Cervical stenosis is typically asymptomatic

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Cervical stenosis: Management

A

Cervical dilatation and catheter insertion to maintain patency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Lower vagina is derived from

A

Urogenital sinus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

All reproductive structures arise from the müllerian system except

A

1) Ovaries (genital ridge)

2) Lower 1/3 of vagina (urogenital diaphragm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Mullerian ducts are aka

A

Paramesonephric ducts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Most common congenital mullerian/uterine anomaly not related to drugs

A

Septate uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Septate uterus is brought about by

A

Malfusion of paramesonephric ducts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

All reproductive structures arise from the müllerian system except

A

1) Ovaries (genital ridge)

2) Lower 1/3 of vagina (urogenital diaphragm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Why septate uterus is related to recurrent ___trimester pregnancy loss

A

First

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Why septate uterus is related to recurrent first-trimester pregnancy loss

A

Septa lack adequate blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Pregnancy complications associated with bicornuate and unicornuate uteri

A

1) 2nd trimester pregnancy loss
2) Malpresentation
3) Preterm labor and delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Why bicornuate and unicornuate uteri are related to pregnancy complications

A

Limited size of uterine horn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Congenital anomaly associated with increased incidence of renal anomalies

A

Mullerian anomaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Most infrequent Mullerian anomaly

A

Uterus didelphys with septate vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

T/F Most uterine myomas cause no major symptoms and require no treatment

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

T/F Most uterine myomas cause no major symptoms and require no treatment

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

T/F Fibroids are also hormonally responsive to both estrogen and progesterone

A

T

94
Q

Leiomyomas of uterus: Most common type

A

Intramural

95
Q

Leiomyomas of uterus: Most commonly associated with heavy or prolonged bleeding

A

Submucosal

96
Q

A pedunculated fibroid that becomes attached to the pelvic viscera or omentum and develops its own blood supply

A

Parasitic leiomyoma

97
Q

T/F Pseudocapsule of leiomyoma has abundant blood vessels and lymphatics

A

F

98
Q

T/F Pseudocapsule of leiomyoma has abundant blood vessels and lymphatics

A

F

99
Q

T/F Leiomyomas enlarge, they can outgrow their blood supply, infarct, and degenerate, causing pain

A

T

100
Q

T/F Leiomyosarcomas arise from leiomyomas

A

F

101
Q

Risk factors for uterine leiomyoma

A

1) Non-smoker
2) Early menarche
3) Nulliparity
4) Perimenopause
5) Increased alcohol use
6) Htn

102
Q

T/F The use of hormone replacement in postmenopausal women with fibroids is as- sociated with fibroid growth but typically does not result in clinical symptoms

A

T

103
Q

T/F The risk of fibroids decreases with oral contraception use

A

T

104
Q

Uterine leiomyoma: Most common symptom

A

AUB, heavy or prolonged bleeding

105
Q

Uterine leiomyoma: Most common symptom

A

AUB

106
Q

Increasingly heavy periods of longer duration

A

Menorrhagia

107
Q

Bleeding between periods

A

Metrorrhagia

108
Q

Heavy irregular bleeding

A

Menometrorrhagia

109
Q

Uterine leiomyoma: Type that most commonly presents with pelvic pain

A

Subserosal pedunculated fibroid (due to vascular compromise)

110
Q

T/F Leiomyomas enlarge, they can outgrow their blood supply, infarct, and degenerate, causing pain

A

T

111
Q

T/F Leiomyosarcomas arise from leiomyomas

A

F

112
Q

Fibroid characteristics that may contribute to increased rates of pregnancy complications

A

1) Multiple
2) Large, 5-10 cm
3) Located behind the placenta

113
Q

T/F The use of hormone replacement in postmenopausal women with fibroids is as- sociated with fibroid growth but typically does not result in clinical symptoms

A

T

114
Q

T/F The risk of fibroids decreases with oral contraception use

A

T

115
Q

T/F The risk of fibroids decreases with injectable depot medroxyproges- terone acetate use

A

T

116
Q

Uterine leiomyoma: Most common symptom

A

AUB

117
Q

Increasingly heavy periods of longer duration

A

Menorrhagia

118
Q

Bleeding between periods

A

Metrorrhagia

119
Q

Uterine leiomyoma: Treatment that may be given prior to surgical treatment of uterine fibroids to shrink fibroid size, stop bleeding, and increase the hematocrit

A

GnRH agonists

120
Q

Less invasive surgical approach for treating symptomatic fibroids that are large and pedunculated

A

Uterine artery embolization

121
Q

Blood vessel catheterised to reach the uterine artery in uterine artery embolization

A

Femoral artery

122
Q

Uterine leiomyoma: Type unlikely to affect conception or pregnancy loss

A

1) Subserous

2) Intramural

123
Q

T/F Majority of women with fibroids are able to conceive without any difficulties

A

T

124
Q

Fibroid characteristics that may contribute to increased rates of pregnancy complications

A

1) Multiple
2) Large, 5-10 cm
3) Located behind the placenta

125
Q

Indications for Surgical Intervention for Uterine Leiomyomas

A

1) Abnormal uterine bleeding, causing anemia
2) Severe pelvic pain or secondary amenorrhea
3) Uterine size > 12 wk obscuring evaluation of adnexa
4) Urinary frequency, retention, or hydronephrosis
5) Growth after menopause
6) Recurrent miscarriage or infertility
7) Rapid increase in size

126
Q

Uterine leiomyoma: Most common means of diagnosis

A

Pelvic ultrasound

127
Q

Hysterectomy for leiomyoma: Age for which ovaries should be preserved

A

Younger than 45 years with normal- appearing ovaries

128
Q

Diagnostic modality especially helpful in distinguishing fibroids from adenomyosis as well as for surgical planning

A

MRI

129
Q

Actively growing fibroids should be monitored every

A

6 months

130
Q

Uterine leiomyoma: Treatment associated with shrinkage of fibroids, decrease in bleeding, and increase in hct by decreasing circulating estrogen levels

A

GnRH agonists

131
Q

Uterine leiomyoma: Treatment that may be given prior to surgical treatment of uterine fibroids to shrink fibroid size, stop bleeding, and increase the hematocrit

A

GnRH agonists

132
Q

Less invasive surgical approach for treating symptomatic fibroids

A

Uterine artery embolization

133
Q

Blood vessel catheterised to reach the uterine artery in uterine artery embolization

A

Femoral artery

134
Q

T/F UAE should not be used in women who are planning to become pregnant after the procedure

A

T

135
Q

New option for management of uterine fibroids typically reserved for premenopausal women who have completed childbearing and wish to retain their uterus

A

MRI-guided high-intensity ultrasound

136
Q

Uterine leiomyoma: Primary disadvantage of myomectomy

A

1) Recurrence in more than 60% of patients in 5 years

2) Adhesions

137
Q

Endometrial hyperplasia: Brought about by

A

Unopposed endogenous or exogenous estrogen

138
Q

Definitive treatment for leiomyoma

A

Hysterectomy

139
Q

Hysterectomy for leiomyoma: Age for which ovaries should be preserved

A

Younger than 45 years with normal- appearing ovaries

140
Q

T/F Endometrial hyperplasia is the abnormal proliferation of only the glandular elements of the endometrium

A

F, glandular and stromal

141
Q

Localized benign overgrowths of endo- metrial glands and stroma over a vascular core

A

Endometrial polyps

142
Q

Endometrial polyps: Most common age group

A

40-50

143
Q

Endometrial polyps: Risk factor/s

A

Tamoxifen

144
Q

Endometrial polyps: Most common presentation

A

Abnormal vaginal bleeding

145
Q

Endometrial polyps: Accounts for ___% of all causes of postmenopausal bleeding

A

25

146
Q

Classification of endometrial hyperplasia: Carries a higher risk of progression to endometrial cancer and may have coexistent endometrial cancer

A

Atypical hyperplasia

147
Q

Women 45 or older with abnormal bleeding from en- dometrial polyps should be evaluated with ___ prior to removal

A

Endometrial biopsy

148
Q

Endometrial polyps: Can be malignant or premalignant

A

T

149
Q

Endometrial hyperplasia: Brought about by

A

Unopposed estrogen

150
Q

Most common exogenous source of estrogen

A

HRT w/o progesterone

151
Q

Source of increased oestrogen in obese women

A

Peripheral conversion of androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) by AROMATASE

152
Q

Property of tamoxifen that increases the risk of endometrial hyperplasia

A

Weak estrogenic agonist activity

153
Q

Endometrial hyperplasia: Only architectural changes are present

A

Simple or complex

154
Q

Endometrial hyperplasia: When cytologic atypic is present

A

Atypical simple or atypical complex

155
Q

Architectural changes vs cytologic atypia: Changes in complexity and crowding of the glandular components of the endometrium

A

Architectural changes

156
Q

Architectural changes vs cytologic atypia: Changes in the cellular structure of the endometrial cells

A

Cytologic atypia

157
Q

T/F Tissue diagnosis is required for the diagnosis of endometrial hyperplasia

A

T

158
Q

Classification of endometrial hyperplasia: Carries a higher risk of progression to endometrial cancer and may have coexistent endometrial cancer

A

Atypical hyperplasia

159
Q

Classification of endometrial hyperplasia: Abnormal proliferation of both the stromal and glandular endometrial elements

A

Simple hyperplasia

160
Q

Classification of endometrial hyperplasia: Abnormal proliferation of the glandular endometrial elements without prolifera- tion of the stromal elements

A

Complex hyperplasia

161
Q

Classification of endometrial hyperplasia: Cellular atypia and mitotic figures in addition to glandular crowding and complexity

A

Atypical hyperplasia

162
Q

Classification of endometrial hyperplasia: Glands are crowded in a back-to-back fashion and are of varying shapes and sizes, but no cytologic atypia is present

A

Complex hyperplasia

163
Q

Duration of progestin treatment for endometrial hyperplasia

A

3-6 months, then repeat EMB

164
Q

Endometrial hyperplasia: Management after treatment to prevent recurrence

A

Regular cyclic or continuous progestin

165
Q

Independent risk factors for endometrial hyperplasia

A

1) Htn

2) DM

166
Q

Syndrome related to a 10-fold increased lifetime risk for endometrial hyperplasia and cancer

A

Lynch II syndrome (HNPCC)

167
Q

Typical presentation of endometrial hyperplasia

A

Long periods of oligomenorrhea or amenorrhea followed by irregular or excessive uterine bleeding

168
Q

Stigmata associated with chronic anovulation

A

1) Obesity
2) Acanthosis
3) Acne
4) Hirsutism

169
Q

Duration of progestin treatment for endometrial hyperplasia that is predictive of failure

A

9 months

170
Q

Method of choice for evaluation of abnormal uterine bleeding including that from endometrial hyperplasia

A

Endometrial biopsy

171
Q

Indications for D&C in ruling out endometrial hyperplasia and cancer

A

1) Insufficient tissue
2) Patient discomfort
3) Cervical stenosis
4) Atypical complex hyperplasia on biopsy (coexistent endometrial Ca

172
Q

Endometrial hyperplasia: Goal of treatment

A

1) Prevent progression of disease

2) Control abnormal bleeding

173
Q

Treatment for simple and complex hyperplasia without atypia

A

Progestin

174
Q

Progestin MOA for endometrial hyperplasia

A

Activation of progestin receptors, resulting in stromal decidualization and thinning of endometrium

175
Q

Follicular cysts: Size that can lead to pelvic pain, ovarian torsion, and dyspareunia

A

> 4cm

176
Q

Treatment of choice for women with endometrial hyperplasia with atypia who do not desire future fertility

A

Hysterectomy

177
Q

Population of women most commonly with atypical complex hyperplasia

A

1) Perimenopausal

2) Postmenopausal

178
Q

Management recommended for younger patients with atypical complex hyperplasia and chronic anovulation who wish to preserve fertility or if the patient is a poor surgical candidate

A

1) Longer-term progestin

2) Weight loss

179
Q

When to repeat EMB after longer-term progestin and weight loss

A

3 months

180
Q

Duration of progestin treatment for endometrial hyperplasia that is predictive of failure

A

9 months

181
Q

T/F Functional cysts of the ovaries result from normal physiologic functioning of the ovaries

A

T

182
Q

Cysts that can cause a amenorrhea or delay in menstruation and dull lower quadrant pain

A

Corpus luteum cysts

183
Q

Condition: Acute pain and signs of hemoperitoneum late in the luteal phase

A

1) Ruptured corpus luteum cyst
2) Ovarian torsion
3) Hemorrhagic corpus luteum cyst

184
Q

Follicular cysts: T/F Classically asymptomatic

A

T

185
Q

Follicular cysts: T/F Usually bilateral

A

F, unilateral

186
Q

Theca lutein cysts: Result from

A

Stimulation by abnormally high ß-human chorionic gonadotropin

187
Q

Follicular cysts: T/F Most resolve spontaneously

A

T

188
Q

Follicular cysts: Expected duration of resolution

A

60-90 days

189
Q

Normal size of an ovarian follicle (physiologic cyst)

A

Less than 2.5 cm

190
Q

2 types of functional ovarian cysts

A

1) Follicular cysts

2) Corpus luteum cysts

191
Q

Increases the risk for functional cysts twofold

A

Smoking

192
Q

Corpus luteum cysts: Arise from

A

Failure of corpus luteum to regress after 14 days and becomes enlarged to > 3cm or hemorrhagic

193
Q

Cysts that can cause a delay in menstruation and dull lower quadrant pain

A

Corpus luteum cysts

194
Q

Condition: Acute pain and signs of hemoperitoneum late in the luteal phase

A

Ruptured corpus luteum cyst

195
Q

Large cysts filled with clear, straw-colored fluid

A

Theca lutein cysts

196
Q

Theca lutein cysts: T/F Usually bilateral

A

T

197
Q

Theca lutein cysts: Result from

A

Stimulation by abnormally high ß-human chorionic gonadotropin

198
Q

Sources of high ß-human chorionic gonadotropin

A

1) Molar pregnancy
2) Choriocarcinoma
3) Ovulation induction therapy

199
Q

Growth of ectopic endo- metrial tissue within the ovary

A

Endometerioma

200
Q

Nonfunctional neoplasm vs functional cysts: Most common ovarian masses in women of reproductive age

A

Functional cysts

201
Q

Functional ovarian cysts can be found most commonly in what age group

A

Between puberty and menopause

202
Q

Increases the risk for functional cysts twofold

A

Smoking

203
Q

Management of a cystic adnexal mass: Reproductive age, simple cyst more than 7 cm

A

Further imaging or surgical evaluation

204
Q

Functional ovarian cysts: Generally larger (greater than 8 cm)

A

Lutein cysts

205
Q

Functional ovarian cysts: T/F A ruptured cyst can cause pain on palpation, acute abdominal pain, and rebound tenderness

A

T

206
Q

Classic presentation of ovarian torsion

A

1) Waxing and waning pain

2) Nausea and vomiting

207
Q

Functional ovarian cysts: Tend to be simple or unilocular

A

Follicular

208
Q

Primary diagnostic tool for the workup of ovarian cyst

A

Pelvic ultrasound

209
Q

Diagnostic tool used to check for cyst resolution

A

Serial ultrasounds

210
Q

CA-125: Screening/diagnosis vs response to treatment

A

Response to treatment

211
Q

Management of a cystic adnexal mass: Premenarchal, more than 2 cm

A

Surgical evaluation

212
Q

Management of a cystic adnexal mass: Reproductive age, simple cyst less than or equal to 5 cm

A

No follow-up necessary

213
Q

Management of a cystic adnexal mass: Reproductive age, simple cyst more than 5 cm but less than 7 cm

A

Repeat ultrasound after 1 year

214
Q

Management of a cystic adnexal mass: Reproductive age, simple cyst more than 7 cm

A

Further imaging or surgical evaluation

215
Q

Management of a cystic adnexal mass: Reproductive age, hemorrhagic less than or equal to 5 cm

A

No follow up necessary

216
Q

Management of a cystic adnexal mass: Reproductive age, hemorrhagic more than 5 cm

A

Repeat ultrasound in 6-12 weeks

217
Q

Management of a cystic adnexal mass: Reproductive age, endometrioma

A

Repeat ultrasound in 6-12 weeks; surgically remove or follow yearly

218
Q

Management for cysts that do not resolve within 60-90 days

A

Cystectomy or oophorectomy

219
Q

Medical treatment options to shrink leiomyoma

A

1) Provera
2) Danazol
3) GnRH analogs

220
Q

Management of a cystic adnexal mass: Postmenopausal, simple more than 1 but less than or equal to 7 cm

A

Repeat ultrasound in 1 year

221
Q

Management of a cystic adnexal mass: Postmenopausal, more than 7 cm

A

Further imaging or surgical evaluation

222
Q

Management of a cystic adnexal mass: Early postmenopausal, hemorrhagic

A

Repeat ultrasound in 6-12 weeks

223
Q

Management of a cystic adnexal mass: Late menopause, hemorrhagic

A

Surgical evaluation

224
Q

Management of a cystic adnexal mass: Postmenopausal, nodule without flow or multiple thin septations

A

Surgical evaluation or MRI

225
Q

A palpable ovary or adnexal mass in a premenarchal or post- menopausal patient is suggestive of

A

Ovarian neoplasm > functional cyst

226
Q

Reproductive-age women with cysts larger than 7 cm or that persist or that are solid or complex on ultrasound are suggestive of

A

Ovarian neoplasm > functional cyst

227
Q

May be given to patients with follicular cysts during the 60-90-day observation period

A

OCPs

228
Q

MOA of OCPs during the 60-90-day observation period for follicular cysts

A

Suppress ovulation to prevent formation of future cysts

229
Q

Management for cysts that do not resolve within 60-90 days

A

Cystectomy or oophorectomy

230
Q

Medical treatment options to shrink leiomyoma

A

1) Provera
2) Danazol
3) GnRH analogs